FDA & Government News

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Share

A new initiative by the American Medical Association (AMA) and the Vaccine Integrity Project aims to assess the safety and effectiveness of influenza, COVID-19, and RSV vaccines for the 2026-2027 season. This comes in response to concerns over the current state of vaccine recommendation practices following the dismissal of ACIP members. The structured review process will involve expert panels, systematic literature reviews, and transparent public protocols. The goal is to restore trust in vaccine recommendations through evidence-based guidance for various population groups.

Original Source(s)

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

  • by Kathryn Wighton

  • February 11, 2026

  • 4 min

Related Content

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Medical Oddities: When Body Fat Gets to Your Head

From colds to cognition, these studies show how everyday science—viruses, fat, bones, herbs, even AI— meets fine the print.

US Leaves WHO Over Pandemic, Governance

The announcement describes a shift toward direct engagement with countries and organizations outside the World Health Organization.